#Mwebantu, it is firing season. Another government official fired!

 PRESIDENT Hakainde Hichilema has with immediate effect terminated the contract Ministry of Mines and Minerals Development permanent secretary Mooya Lumamba. State House chief communications specialist Clayson Hamasaka said in a statement this evening the termination is pursuant to the provisions of Article 92 as read with Article 270 of the Constitution of the Republic of […]

Fewer surveillance MRIs may be appropriate for patients with incidental pituitary lesions

A cohort study of persons with incidental pituitary microadenomas found that approximately two-thirds of the microadenomas remained unchanged or decreased in size over time. These findings suggest that less frequent pituitary magnetic resonance imaging (MRI) surveillance for patients with incidental pituitary microadenomas may be safe. The findings are published in Annals of Internal Medicine.

Imagination is a spectrum, and 1% of people can’t mentally visualize things at all

When you hear someone talk, do you see the words in your mind’s eye? Or do you see what they’re saying as a movie? It’s easy to assume that the way you perceive the world is the same for everyone. But recent studies have revealed that there is a wide spectrum of how people visualize things in their mind’s eye. The vividness of your inner visual imagery can even change throughout your life.

Tracing a rare smooth muscle disorder to a single mutation in a non-coding gene

A team of investigators from Massachusetts General Hospital (MGH), a founding member of Mass General Brigham (MGB) and Mass General for Children (MGfC) has identified—for the first time—the mutation in a single non-coding gene of a young patient responsible for the extremely rare disease known as multisystemic smooth muscle dysfunction syndrome (MSMDS), which causes profound cerebrovascular, gastrointestinal and urologic impairment.

Digital twin opens way to effective treatment of inflammatory diseases

Inflammatory diseases like rheumatoid arthritis have complex disease mechanisms that can differ from patient to patient with the same diagnosis. This means that currently available drugs have little effect on many patients. Using so-called digital twins, researchers at Karolinska Institutet have now obtained a deeper understanding of the “off and on” proteins that control these diseases. The study, which is published in Cell Reports Medicine, can lead to more personalized drug therapies.